Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Antiangiogenic treatment of ocular diseases.

Sundlisæter E, Tvedt C.

Tidsskr Nor Laegeforen. 2018 Nov 5;138(18). doi: 10.4045/tidsskr.17.1083. Print 2018 Nov 13. English, Norwegian. No abstract available.

2.

Inhibition of Endothelial NOTCH1 Signaling Attenuates Inflammation by Reducing Cytokine-Mediated Histone Acetylation at Inflammatory Enhancers.

Poulsen LC, Edelmann RJ, Krüger S, Diéguez-Hurtado R, Shah A, Stav-Noraas TE, Renzi A, Szymanska M, Wang J, Ehling M, Benedito R, Kasprzycka M, Bækkevold E, Sundnes O, Midwood KS, Scott H, Collas P, Siebel CW, Adams RH, Haraldsen G, Sundlisæter E, Hol J.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):854-869. doi: 10.1161/ATVBAHA.117.310388. Epub 2018 Feb 15.

PMID:
29449332
3.

Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture.

Rajcevic U, Knol JC, Piersma S, Bougnaud S, Fack F, Sundlisaeter E, Søndenaa K, Myklebust R, Pham TV, Niclou SP, Jiménez CR.

Proteome Sci. 2014 Jul 11;12:39. doi: 10.1186/1477-5956-12-39. eCollection 2014.

4.

Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells.

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):e47-55. doi: 10.1161/ATVBAHA.112.253427. Epub 2012 Nov 15.

PMID:
23162017
5.

The alarmin IL-33 is a notch target in quiescent endothelial cells.

Sundlisaeter E, Edelmann RJ, Hol J, Sponheim J, Küchler AM, Weiss M, Udalova IA, Midwood KS, Kasprzycka M, Haraldsen G.

Am J Pathol. 2012 Sep;181(3):1099-111. doi: 10.1016/j.ajpath.2012.06.003. Epub 2012 Jul 16.

PMID:
22809957
6.

[Complications after gastrointestinal surgery].

Sundlisaeter E, Mjåland O.

Tidsskr Nor Laegeforen. 2009 Oct 22;129(20):2098-102. doi: 10.4045/tidsskr.09.0001. Norwegian. No abstract available.

7.

Increased lymphatic vascular density is seen before colorectal cancers reach stage II and growth factor FGF-2 is downregulated in tumor tissue compared with normal mucosa.

Sundlisaeter E, Røsland GV, Hertel JK, Sakariassen PØ, Almås B, Dicko A, Søndenaa K.

APMIS. 2009 Mar;117(3):212-21. doi: 10.1111/j.1600-0463.2008.00025.x.

PMID:
19245594
8.

Lymphangiogenesis in colorectal cancer--prognostic and therapeutic aspects.

Sundlisaeter E, Dicko A, Sakariassen PØ, Sondenaa K, Enger PØ, Bjerkvig R.

Int J Cancer. 2007 Oct 1;121(7):1401-9. Review.

9.

Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Sakariassen PØ, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, Molthoff C, Sminia P, Sundlisaeter E, Misra A, Tysnes BB, Chekenya M, Peters H, Lende G, Kalland KH, Øyan AM, Petersen K, Jonassen I, van der Kogel A, Feuerstein BG, Terzis AJ, Bjerkvig R, Enger PØ.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16466-71. Epub 2006 Oct 20.

10.

Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation.

Sundlisaeter E, Wang J, Sakariassen PØ, Marie M, Mathisen JR, Karlsen BO, Prestegarden L, Skaftnesmo KO, Bjerkvig R, Enger PØ.

Neuropathol Appl Neurobiol. 2006 Aug;32(4):419-27.

PMID:
16866987

Supplemental Content

Loading ...
Support Center